Moreover, based on aforementioned dCas9 approaches targeting CTCF looping or the tools targeting enhancer–promoter interactions, we could investigate whether manipulation of the 3D chromatin architectures in precancerous stage can halt the HCC development in animal model and this strategy could be applied to other cancer types. This evidence concerns the gene CTCF and cancer.